<DOC>
	<DOC>NCT00483002</DOC>
	<brief_summary>To monitor use in real practice including safety and efficacy of Champix tablets 0.5mg, 1mg medication for 12 weeks in smokers</brief_summary>
	<brief_title>Post Marketing Surveillance Study To Observe Safety And Efficacy Of ChampixÂ® Tablets</brief_title>
	<detailed_description>No sampling method will be applied to this study.</detailed_description>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Subjects selected for this study are those who would have been prescribed Champix tablets by the physician according to the subject's condition in usual clinical practice.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>A prospective and observational program to monitor use in real practice including efficacy of Varenicline in Korea.</keyword>
</DOC>